Safety Shot, Inc. (SHOT)
NASDAQ: SHOT · Real-Time Price · USD
0.3040
+0.0340 (12.59%)
At close: Jun 18, 2025, 4:00 PM
0.3098
+0.0058 (1.91%)
After-hours: Jun 18, 2025, 7:57 PM EDT
Company Description
Safety Shot, Inc. provides over-the-counter products and consumer products in the United States.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content.
It also provides hair loss treatment, vitiligo solution, eczema cream, and sexual wellness products. It sells its products through direct customers, distributors, retailers, and e-commerce websites.
The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.
Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Safety Shot, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Oct 30, 2020 |
| Industry | Beverages - Non-Alcoholic |
| Sector | Consumer Staples |
| Employees | 8 |
| CEO | Jarrett Boon |
Contact Details
Address: 1061 East Indiantown Road, Suite 110 Jupiter, Florida 33477 United States | |
| Phone | 561 244 7100 |
| Website | safetyshotofficial.com |
Stock Details
| Ticker Symbol | SHOT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $7.50 |
| CIK Code | 0001760903 |
| CUSIP Number | 48208F105 |
| ISIN Number | US48208F1057 |
| Employer ID | 83-2455880 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Jarrett A. Boon | Chief Executive Officer and Director |
| Jordan Schur | President and Director |
| Danielle De Rosa-Diaz | Chief Financial Officer |
| David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC | Chief Operating Officer |
| Anthony Pedicelli | Director of Marketing |
| Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
| Josh Wagner | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 16, 2025 | 8-K | Current Report |
| Jun 13, 2025 | 8-K | Current Report |
| Jun 6, 2025 | EFFECT | Notice of Effectiveness |
| Jun 4, 2025 | 8-K | Current Report |
| Jun 3, 2025 | 8-K | Current Report |
| Jun 2, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 29, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 29, 2025 | 8-K | Current Report |
| May 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 28, 2025 | 8-K | Current Report |